About M. Ramana Rameswaran
With practical in-house experience inside the health care and pharmaceutical industries, Ramana Rameswaran helps clients nationally throughout these industries on a range of regulatory, transactions, investigatory, and compliance matters. Whether advising private equity funds, physician practices, hospitals and health systems on structuring M&A transactions and joint ventures, or combatting fraud and abuse, Ramana is a trusted voice who understands his clients' business concerns.
Legal perspective shaped by medical knowledge and in-house experience
Muthuramanan "Ramana" Rameswaran counsels clients on major M&A transactions and joint ventures particularly involving health care private equity transactions. Ramana also provides strategic guidance on health care regulatory issues related to state and federal fraud and abuse laws, telehealth, corporate practice of medicine, operational issues, provider reimbursement, clinical trials, and more. He also assists with health care policy analysis and advocacy.
Ramana also uses his in-house experience from his time at Temple University Health System, a Philadelphia-area hospital system, and from Avantor Performance Materials, a performance materials manufacturer for chemicals in the electronics and health sciences industry, to provide outside general counsel support. In addition to traditional health care providers, Ramana has worked extensively with pharmaceutical and medical device manufacturers and suppliers. He has practiced health care law in both Washington, DC and Pennsylvania.
Ramana was a member of the Governing Council of the American Bar Association's Health Law Section for over four years and continues to be an active leader in the organization. He is also an Eagle Scout, an active nationally registered EMT, and an active certified emergency medical services instructor for the Commonwealth of Pennsylvania.
Before attending law school, Ramana attended Temple University School of Medicine and completed course work and clinical rotations towards an MD degree. He also has worked at Merck Sharpe & Dohme, making measles, mumps and rubella vaccine in a good manufacturing practices-environment.
- Health care entities and pharmaceutical manufacturers and suppliers
- Federal and state fraud and abuse compliance, including Anti-Kickback Statute and Stark Law compliance
- Complex co-management, consulting and physician arrangements
- Large-scale supply-chain arrangements, including GPO arrangements
- Health IT and privacy
- Corporate practice of medicine
- 340B Drug Discount Program compliance and contracting
July 29, 2021
May 5, 2021
April 16, 2020
March 3, 2020
October 2011Pro Bono: Ambulances Need Tender Loving Care Too
September 2011Pro Bono: Fire Rehab Saves Lives and Reduces Your Liability
2007Atrazine is an Immune Disruptor in Adult Northern Leopard Frogs (Rana pipiens)
2006Acid Exposure is an Immune Disruptor in Adult Rana pipiens
Presentations and Events
June 23, 2021Speaker
January 7, 2021A Practical Guide to The Stark Final Rule: Physician Compensation Arrangement Opportunities and Compliance PitfallsPresenter
April 9, 2020Speaker | Boots on the Ground – Practical Approaches to Integrating Community and Facility COVID-19 Response
June 2018American Health Lawyers AssociationModerator | Easier Said Than Done: Challenges of Implementing Outside Counsel Advice on the Inside
September 2017American Bar AssociationModerator | Career Choice Series: Health Law
March 2017American Bar Association Health Law SectionSpeaker | Ethics Challenges for In-House Counsel and Lawyers Who Advise Them
March 2016American Bar Association Health Law SectionSpeaker | 340B—What Attorneys Need to Know Today, Tomorrow and in the Future
June 2015American Bar Association Health Law SectionModerator | Applying for In-House Positions